Eli Lilly and Company (LLY) Financial Statements & Analysis

Eli Lilly and Company (LLY) Income Statement

Eli Lilly and Company reported revenue of $65.18B in fiscal 2025 (fiscal year ended Dec 31, 2025), up 44.7% from $45.04B a year earlier. Net income was $20.64B, up 94.9% year over year, a net margin of 31.7%. Gross margin was 83.0% and operating margin 40.4%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $22.97B, up 47.7% from the same quarter a year earlier.

Eli Lilly and Company Income Statement Analysis

Values in billions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Eli Lilly and Company income statement - Annual data in billions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Revenue & Gross Profit
Revenue	65.18	45.04	34.12	28.54	28.32	24.54	22.32	21.49	19.97
Cost of Revenue	11.05	8.42	7.08	6.63	7.31	5.48	4.72	4.68	4.45
Gross Profit	54.13	36.63	27.04	21.91	21.01	19.06	17.60	16.81	15.53
Operating Expenses
Research & Development	13.34	10.99	9.31	7.19	6.93	5.98	5.60	5.05	5.10
Selling, General & Administrative	11.09	8.59	6.94	6.44	6.14	5.87	6.00	5.73	6.18
Operating Expenses	27.83	19.59	16.25	13.63	13.07	11.85	11.60	10.79	11.28
Operating Income	26.30	17.04	10.79	8.28	7.93	7.21	6.00	6.03	4.25
Other Income/Expense
Interest Income	0.15	0.18	0.17	0.06	0.03	0.03	0.08	0.16	0.17
Interest Expense	0.80	0.78	0.49	0.33	0.34	0.36	0.40	0.24	0.23
Other Income/Expense	-0.57	-4.36	-4.23	-1.21	-1.78	0.02	-0.73	-2.35	-1.95
Income
Income Before Tax	25.73	12.68	6.55	6.81	6.16	7.23	5.27	3.68	2.30
Income Tax Expense	5.09	2.09	1.31	0.56	0.57	1.04	0.63	0.53	2.39
Net Income	20.64	10.59	5.24	6.24	5.58	6.19	8.32	3.23	-0.20
Net Income - Continuous Operations	20.64	10.59	5.24	6.24	5.58	6.19	8.32	3.23	-0.20
Net Income - Discontinued Operations	-	-	-	-	-	-	-	-	-
EBITDA	31.69	18.81	8.57	8.66	8.04	8.91	6.90	5.53	4.10
EBIT	29.70	17.04	10.33	7.14	8.27	-	-	-	-
Depreciation & Amortization	2.00	1.77	1.53	1.52	1.55	1.32	1.23	1.61	1.57
Earnings Per Share
Basic EPS	23.00	12.00	6.00	7.00	6.00	6.00	9.00	3.00	-
Diluted EPS	23.00	12.00	6.00	7.00	6.00	6.00	9.00	3.00	-
Basic Shares Outstanding	0.90	0.90	0.90	0.95	0.95	0.96	0.96	1.03	1.05
Diluted Shares Outstanding	0.90	0.90	0.90	0.95	0.95	0.96	0.96	1.03	1.05

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Eli Lilly and Company Financial Statements

What was Eli Lilly and Company's revenue in fiscal 2025?

Eli Lilly and Company reported revenue of $65.18B in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 44.7% from $45.04B a year earlier.

Is Eli Lilly and Company profitable?

Yes. Eli Lilly and Company earned net income of $20.64B in fiscal 2025, a net margin of 31.7%. In fiscal 2024 it earned $10.59B.

What is Eli Lilly and Company's operating margin?

Eli Lilly and Company's operating income was $26.30B on revenue of $65.18B in fiscal 2025, an operating margin of 40.4%, compared with 37.8% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition